❗️Роналду мог не заплатить за процедуру поувеличению члена: косметолог, который в частности специализируется на инъекциях ботокса, подал на Криштиану в суд – португалец не оплатил процедуры на 5,2 млн рублей в 2021 и 2022 годах. Тогда же СМИ сообщали, что Роналду якобы колет ботокс себе в член, чтобы увеличить его толщину на 1-3 см — The Sun, La Razon, Marca
❗️Роналду мог не заплатить за процедуру поувеличению члена: косметолог, который в частности специализируется на инъекциях ботокса, подал на Криштиану в суд – португалец не оплатил процедуры на 5,2 млн рублей в 2021 и 2022 годах. Тогда же СМИ сообщали, что Роналду якобы колет ботокс себе в член, чтобы увеличить его толщину на 1-3 см — The Sun, La Razon, Marca
In the United States, Telegram's lower public profile has helped it mostly avoid high level scrutiny from Congress, but it has not gone unnoticed. The news also helped traders look past another report showing decades-high inflation and shake off some of the volatility from recent sessions. The Bureau of Labor Statistics' February Consumer Price Index (CPI) this week showed another surge in prices even before Russia escalated its attacks in Ukraine. The headline CPI — soaring 7.9% over last year — underscored the sticky inflationary pressures reverberating across the U.S. economy, with everything from groceries to rents and airline fares getting more expensive for everyday consumers. As a result, the pandemic saw many newcomers to Telegram, including prominent anti-vaccine activists who used the app's hands-off approach to share false information on shots, a study from the Institute for Strategic Dialogue shows. Perpetrators of these scams will create a public group on Telegram to promote these investment packages that are usually accompanied by fake testimonies and sometimes advertised as being Shariah-compliant. Interested investors will be asked to directly message the representatives to begin investing in the various investment packages offered. The picture was mixed overseas. Hong Kong’s Hang Seng Index fell 1.6%, under pressure from U.S. regulatory scrutiny on New York-listed Chinese companies. Stocks were more buoyant in Europe, where Frankfurt’s DAX surged 1.4%.
from sg
